rs377452683

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_001164507.2(NEB):​c.169_183delCTGGCACAGCCAGCA​(p.Leu57_Ala61del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00456 in 1,611,950 control chromosomes in the GnomAD database, including 100 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 47 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 53 hom. )

Consequence

NEB
NM_001164507.2 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.20

Publications

0 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001164507.2
BP6
Variant 2-151727801-ATGCTGGCTGTGCCAG-A is Benign according to our data. Variant chr2-151727801-ATGCTGGCTGTGCCAG-A is described in ClinVar as [Benign]. Clinvar id is 95115.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0146 (2222/152156) while in subpopulation AFR AF = 0.0448 (1859/41514). AF 95% confidence interval is 0.0431. There are 47 homozygotes in GnomAd4. There are 1067 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 47 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.169_183delCTGGCACAGCCAGCA p.Leu57_Ala61del conservative_inframe_deletion Exon 5 of 182 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.169_183delCTGGCACAGCCAGCA p.Leu57_Ala61del conservative_inframe_deletion Exon 5 of 182 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.169_183delCTGGCACAGCCAGCA p.Leu57_Ala61del conservative_inframe_deletion Exon 5 of 182 5 NM_001164508.2 ENSP00000380505.3 P20929-2
NEBENST00000427231.7 linkc.169_183delCTGGCACAGCCAGCA p.Leu57_Ala61del conservative_inframe_deletion Exon 5 of 182 5 NM_001164507.2 ENSP00000416578.2 P20929-3
NEBENST00000409198.5 linkc.169_183delCTGGCACAGCCAGCA p.Leu57_Ala61del conservative_inframe_deletion Exon 5 of 150 5 ENSP00000386259.1 P20929-4

Frequencies

GnomAD3 genomes
AF:
0.0146
AC:
2219
AN:
152038
Hom.:
47
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0448
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00675
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000419
Gnomad FIN
AF:
0.00537
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00251
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00520
AC:
1291
AN:
248352
AF XY:
0.00432
show subpopulations
Gnomad AFR exome
AF:
0.0468
Gnomad AMR exome
AF:
0.00410
Gnomad ASJ exome
AF:
0.000895
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00423
Gnomad NFE exome
AF:
0.00269
Gnomad OTH exome
AF:
0.00298
GnomAD4 exome
AF:
0.00352
AC:
5136
AN:
1459794
Hom.:
53
AF XY:
0.00327
AC XY:
2375
AN XY:
726068
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0484
AC:
1618
AN:
33428
American (AMR)
AF:
0.00424
AC:
189
AN:
44618
Ashkenazi Jewish (ASJ)
AF:
0.000574
AC:
15
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000269
AC:
23
AN:
85612
European-Finnish (FIN)
AF:
0.00412
AC:
220
AN:
53392
Middle Eastern (MID)
AF:
0.0104
AC:
60
AN:
5744
European-Non Finnish (NFE)
AF:
0.00245
AC:
2718
AN:
1110896
Other (OTH)
AF:
0.00486
AC:
293
AN:
60278
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.399
Heterozygous variant carriers
0
272
543
815
1086
1358
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0146
AC:
2222
AN:
152156
Hom.:
47
Cov.:
32
AF XY:
0.0143
AC XY:
1067
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0448
AC:
1859
AN:
41514
American (AMR)
AF:
0.00674
AC:
103
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000419
AC:
2
AN:
4768
European-Finnish (FIN)
AF:
0.00537
AC:
57
AN:
10612
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00251
AC:
171
AN:
68016
Other (OTH)
AF:
0.0104
AC:
22
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
97
194
292
389
486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000960
Hom.:
0
Bravo
AF:
0.0157
EpiCase
AF:
0.00202
EpiControl
AF:
0.00214

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 20, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: NEB c.169_183del15 (p.Leu57_Ala61del) results in an in-frame deletion that is predicted to remove 5 amino acids from the encoded protein. The variant allele was found at a frequency of 0.0052 in 248352 control chromosomes in the gnomAD database, including 21 homozygotes. The observed variant frequency is approximately 1.5-fold of the estimated maximal expected allele frequency for a pathogenic variant in NEB causing Nemaline Myopathy 2 phenotype (0.0035), strongly suggesting that the variant is benign. Three ClinVar submitters (evaluation after 2014) have cited the variant, and all laboratories classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -

Dec 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 11, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NEB: PM4, BP4, BS1, BS2 -

Nemaline myopathy 2 Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=200/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377452683; hg19: chr2-152584315; API